Investor Center

Investor Relations

MedAssets is a healthcare performance improvement company. We help providers realize financial and operational gains so that they can sustainably serve the needs of their community. We combine our cloud-based data and analytics tools with cost and clinical resource management, group purchasing, change management consulting, embedded management and revenue cycle services to deliver sustainable financial, operational and clinical performance. We demonstrate the full value we can deliver to healthcare organizations in our ability to:

  • Reduce Total Cost of Care through a systemic approach to drive sustainable change for healthcare organizations

  • Enhance Operational Efficiency through Lean and process improvement programs to decrease overall length-of-stay

  • Align Clinical Delivery by assessing clinical performance and implementing processes to reduce variation in care delivery

  • Improve Revenue Performance with cloud-based analytics tools and expert services for defensible pricing, compliance and reimbursement
     

MedAssets currently manages approximately $51 billion in total spending by hospitals and other healthcare providers, and touches more than $400 billion in gross patient revenue annually. Our technology-enabled services seamlessly integrate with our clients' existing IT systems infrastructure, with minimal upfront cost.

We challenge convention to help push the healthcare industry forward. We understand the unique needs of each client, and the specialized talents of our people reflect our passion for improving healthcare. We employ approximately 3,200 men and women who advise, support and perform the core business operations of more than 4,400 hospitals and 122,000 non-acute healthcare providers.

MedAssets is committed to serving the best interests of our stockholders, clients and employees. On these pages, you can find important, valuable corporate and financial information to help you gain a better perspective of the MedAssets business operations and financial performance.

 

($ in millions, except EPS)

1 Pro Forma for Broadlane acquisition in 2010

Recent Releases

Jul 16, 2014
U.S. Market Cap Guidelines Updated and Constituent Changes Announced for the S&P SmallCap 600

Jul 16, 2014
Baylor Scott & White Health Renews and Expands Relationship With MedAssets to Standardize and Streamline Operations Across Merged Enterprise